Erythroid failure in Diamond-Blackfan anemia is characterized by apoptosis.

Blood

Jack and Lucy Clark Department of Pediatrics, Mount Sinai School of Medicine, New York, NY 10029.

Published: February 1994

Programmed cell death, also known as apoptosis, is frequently initiated when cells are deprived of specific trophic factors. To investigate if accelerated apoptosis contributes to the pathogenesis of Diamond-Blackfan anemia (DBA), a rare pure red blood cell aplasia of childhood, we studied the effect of erythropoietin (epo) deprivation on erythroid progenitors and precursors from the bone marrow of DBA patients as compared with hematologically normal controls. Apoptosis in response to epo deprivation was evaluated by enumeration of colony-forming unit-erythroid (CFU-E)- and burst-forming unit-erythroid (BFU-E)-derived colonies in plasma clot semisolid culture and by the identification of typical DNA oligosomes by gel electrophoresis from marrow mononuclear cells in liquid culture. In all DBA patients there was a marked decrease in CFU-E- and BFU-E-derived colony formation compared with normal controls at comparable time points of epo deprivation, with a complete loss of CFU-E-derived colonies in semisolid culture by 9 hours of epo deprivation versus 48 hours in controls. The BFU-E-derived colony response to epo deprivation displayed a similar pattern of decrement. Apoptotic changes assessed by the presence of characteristic DNA fragmentation began in the absence of epo deprivation and were readily detected within 3 hours of epo deprivation in DBA cultures versus 9 hours in controls. We conclude that DBA is characterized by accelerated apoptosis as measured by the loss of erythroid progenitor clonogenicity and increased progenitor and precursor DNA fragmentation leading to the formation of characteristic oligosomes, consistent with an intrinsic erythroid-progenitor defect in which increased sensitivity to epo deprivation results in erythroid failure.

Download full-text PDF

Source

Publication Analysis

Top Keywords

epo deprivation
32
erythroid failure
8
diamond-blackfan anemia
8
accelerated apoptosis
8
epo
8
deprivation
8
deprivation erythroid
8
dba patients
8
normal controls
8
response epo
8

Similar Publications

Article Synopsis
  • Hypoxic-ischemic encephalopathy (HIE) is a condition causing brain injury from lack of oxygen and blood flow, mainly seen in newborns but can also affect adults; mesenchymal stem cell (MSC) therapies show promise in improving brain function after HIE.
  • Research indicates that human umbilical cord MSCs (hUC-MSCs) express more erythropoietin (EPO) the longer they are exposed to hypoxia, and EPO can be secreted to aid in neuroprotection.
  • The study employs techniques like flow cytometry, RNA sequencing, and CRISPR to explore how EPO-MSCs could reduce inflammation and apoptosis in brain cells after HIE, aiming
View Article and Find Full Text PDF
Article Synopsis
  • Erythropoietin (EPO) is a key growth factor that helps reduce cell death, manage oxidative stress, and promote new blood vessel formation (angiogenesis) in various tissues.
  • In a study using BALB/c mice, researchers compared the effects of EPO treatment versus no treatment and saline injection on brain angiogenesis.
  • The results showed that chronic treatment with recombinant human erythropoietin (rHuEPO) significantly increased the number of blood vessels in healthy mouse brains by 44%, indicating that lesions or low oxygen levels are not required for EPO's angiogenic effects.
View Article and Find Full Text PDF

Pharmacological induction of the hypoxia response pathway in Huh7 hepatoma cells limits proliferation but increases resilience under metabolic stress.

Cell Mol Life Sci

July 2024

CIRI, Centre International de Recherche en Infectiologie, Team Viral Infection, Metabolism and Immunity, Univ Lyon, Inserm, U1111, CNRS, UMR5308, Université Claude Bernard Lyon 1, Ecole Normale Supérieure de Lyon, 69007, Lyon, France.

The hypoxia response pathway enables adaptation to oxygen deprivation. It is mediated by hypoxia-inducible factors (HIF), which promote metabolic reprogramming, erythropoiesis, angiogenesis and tissue remodeling. This led to the successful development of HIF-inducing drugs for treating anemia and some of these molecules are now in clinic.

View Article and Find Full Text PDF

Saracatinib prompts hemin-induced K562 erythroid differentiation but suppresses erythropoiesis of hematopoietic stem cells.

Hum Cell

May 2024

Department of Obstetrics and Gynecology, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, The Third Affiliated Hospital of Guangzhou Medical University, No. 63 Duobao Road, Guangzhou, 510150, Guangdong, China.

Human myeloid leukemia cells (such as K562) could be used for the study of erythropoiesis, and mature erythroid markers and globins could be induced during leukemia cell differentiation; however, the pathways involved are different compared with those of hematopoietic stem cells (HSCs).We identified the differentially expressed genes (DEGs) of K562 cells and HSCs associated with stem cells and erythroid differentiation. Furthermore, we showed that hemin-induced differentiation of K562 cells could be induced by serum starvation or treatment with the tyrosine kinase inhibitor saracatinib.

View Article and Find Full Text PDF

Cellular and tissue adaptations to oxygen deprivation (hypoxia) are necessary for both normal physiology and disease. Responses to hypoxia are initiated by the cellular oxygen sensors prolyl-4-hydroxylase domain (PHD) proteins 1-3 and factor inhibiting HIF (FIH). These enzymes regulate the transcription factor hypoxia-inducible factor (HIF) in a hypoxia-sensitive manner.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!